Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke.
Bruna Pescador MendonçaJuliano Dos Santos CardosoMonique MichelsAna Carolina VieiraDiogo WendhausenAndressa ManfrediniMervyn SingerFelipe Dal-PizzolAlex DysonPublished in: Intensive care medicine experimental (2020)
ATTM confers significant neuroprotection that, along with its known safety profile in humans, provides encouragement for its development as a novel adjunct therapy for revascularization following stroke.